May 11-14, 2026
Hynes Convention CenterBoston, MA Jenny Xie, PhDHead of In Vivo Discovery at Editas MedicineSpeaker
Profile
Jenny Xie joined Editas Medicine in 2024 as Senior Director of Discovery Therapeutics. She brings deep expertise in in vivo drug development, with over 10 years of experience across multiple gene editing platforms and disease indications. In her current role, Jenny oversees Editas’ preclinical in vivo gene editing therapeutics discovery and technology development activities.
Agenda Sessions
Transformative LDL Cholesterol Lowering In Vivo CRISPR Gene Editing Approach for Hyperlipidemia and Atherosclerotic Cardiovascular Disease
, 8:30amView Session